Lagova: Phase II data

An open-label, European Phase II trial in 53 treatment-naive children ages 3-11 with GHD showed that once-weekly 0.25, 0.48 and 0.66 mg/kg hGH-CTP for 12 months led to no treatment-related serious or ...